TABLE 3.

Genotypic analysis^a

Patient	Characterization of genes for:
	CCR5 G-2455A	CCR5 delta 32	CCR2 V64I	RANTES G-403A	RANTES C-28G	MIP-1α T113C	SDF-1 3′A
Controlling group
106	1	1	1	1	1	2	1
107	3	2	1	1	1	1	1
112	3	2	1	1	1	2	1
117	1	1	1	2	1	2	1
118	3	1	2	1	1	1	1
125	2	1	1	2	1	2	3
130	2	1	1	1	1	2	2
Noncontrolling group
102	2	1	1	1	1	2	1
109	2	2	1	1	1	2	1
111	2	1	1	1	1	1	1
113	3	1	2	1	1	2	1
114	2	1	1	1	1	2	1
116	1	1	1	1	1	1	1
119	2	2	1	1	1	1	3
120	2	2	1	1	1	2	3
121	2	2	1	1	1	2	1
122	2	1	1	1	1	2	1
126	2	1	1	1	1	1	2
127	2	1	1	1	1	2	1
128	3	1	2	1	1	1	2

^a1 indicates wild-type genes, and 2 and 3 indicate heterozygosity and homozygosity, respectively, for the mutant gene.